Clinical Trial Update: Tamoxifen in Duchenne Muscular Dystrophy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Tamoxifen in Duchenne Muscular Dystrophy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• Tamoxifen (tamoxifen)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Duchenne Muscular Dystrophy | Phase 3 | Status: COMPLETED